| | 900185-02-6 Basic information More.. |
| Product Name: | PIK-294 | | Synonyms: | 4(3H)-Quinazolinone, 2-[[4-aMino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]Methyl]-5-Methyl-3-(2-Methylphenyl)-;2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-o-tolylquinazolin-4(3H)-one;2-((4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-methyl-3-(o-tolyl)q;PIK-294;2-[[4-Amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone;PIK294;PIK 294;CS-537;PIK-294 USP/EP/BP | | CAS: | 900185-02-6 | | MF: | C28H23N7O2 | | MW: | 489.53 | | EINECS: | | | Mol File: | 900185-02-6.mol |  |
Use
PIK-294 shows distinct patterns of isoform selectivity to inhibit different subsets of class I PI3K isoforms (p110β, p110δ, and p110γ) and exhibits low sensitivity to p110α with IC50 of 10 μM). The m-phenol moiety of PIK-294 is able to penetrate the deep-affinity pocket of the ATP binding site, and thus increases in vitro inhibitory activity.
|
|
900185-02-6
Recommend Suppliers |
|